Jump to content

Portal:Viruses

From Wikipedia, the free encyclopedia
(Redirected from Portal:Virus)

The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus
The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

Hepatocellular carcinoma, a type of liver cancer, in an autopsy specimen from a person positive for hepatitis C

Hepatitis C is an infectious disease affecting mainly the liver, caused by hepatitis C virus (HCV), an RNA virus of the Flaviviridae family which only infects humans and chimpanzees. A "non-A non-B hepatitis" was postulated in the 1970s, and HCV was demonstrated in 1989. HCV is spread primarily by blood-to-blood contact associated with intravenous drug use in the developed world, and with improperly sterilised medical equipment and blood transfusions in the developing world. In about 80% of those infected, the virus establishes a chronic infection in the liver, and around 10–30% of those infected will develop cirrhosis over 30 years. Some people with cirrhosis go on to develop liver failure, liver cancer or other serious complications.

An estimated 143 million people worldwide (2%) have chronic HCV infections as of 2015. The prevalence is highest in Central and East Asia, North Africa and the Middle East. The virus causes around a quarter of cases of cirrhosis and hepatocellular carcinoma, and is a major reason for liver transplantation. The recommended therapy is an appropriate combination of protease inhibitors. Although 95% of people treated in this way are cured, the treatments are expensive and older therapies are less effective. No vaccine against hepatitis C is available.

Selected image

Culex mosquito larvae

Culex species mosquitoes transmit West Nile virus. Elimination of the stagnant water pools where the mosquitoes breed, together with other mosquito control measures, is key to preventing disease.

Credit: James Gathany (28 February 2006)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data
Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

Ribbon diagram of HIV reverse transcriptase
Ribbon diagram of HIV reverse transcriptase

Reverse transcriptase is an enzyme that generates complementary DNA from an RNA template, in contrast to the usual information flow from DNA to RNA. It was discovered in Rous sarcoma virus and murine leukaemia virus, two retroviruses, by Howard Temin and David Baltimore, working independently in 1970, for which the two shared the Nobel Prize in Physiology or Medicine.

Reverse transcription is essential for the replication of retroviruses, allowing them to integrate into the host genome as a provirus. The enzyme is a target for reverse-transcriptase inhibitors, a major class of anti-HIV drugs. Reverse transcription is also used by Hepadnaviridae and Caulimoviridae, DNA viruses that replicate via an RNA intermediate, such as hepatitis B. The process is important in the movement of retrotransposons, a type of mobile genetic element, and in the extension of chromosome ends in eukaryotic genomes. The enzyme is widely used in the laboratory for molecular cloning, RNA sequencing, polymerase chain reaction and genome analysis.

Selected outbreak

Passengers in Mexico City wearing face masks in an attempt to prevent infection
Passengers in Mexico City wearing face masks in an attempt to prevent infection

The 2009 flu pandemic was an influenza pandemic first recognised in Mexico City in March 2009 and declared over in August 2010. It involved a novel strain of H1N1 influenza virus with genes from five different viruses, which resulted when a previous triple reassortment of avian, swine and human influenza viruses further combined with a Eurasian swine influenza virus, leading to the term "swine flu" being used for the pandemic. It was the second pandemic to involve an H1N1 strain, the first being the 1918 "Spanish flu" pandemic.

The global infection rate was estimated as 11–21%. This pandemic strain was less lethal than previous ones, killing about 0.01–0.03% of those infected, compared with 2–3% for Spanish flu. Most experts agree that at least 284,500 people died, mainly in Africa and Southeast Asia – comparable with the normal seasonal influenza fatalities of 290,000–650,000 – leading to claims that the World Health Organization had exaggerated the danger.

Selected quotation

Ed Rybicki

Viruses & Subviral agents: bat virome • elephant endotheliotropic herpesvirus • HIV • introduction to viruses • Playa de Oro virus • poliovirus • prion • rotavirus • virus

Diseases: colony collapse disorder • common cold • croup • dengue fever • gastroenteritis • Guillain–Barré syndrome • hepatitis B • hepatitis C • hepatitis E • herpes simplex • HIV/AIDS • influenza • meningitis • myxomatosis • polio • pneumonia • shingles • smallpox

Epidemiology & Interventions: 2007 Bernard Matthews H5N1 outbreak • Coalition for Epidemic Preparedness Innovations • Disease X • 2009 flu pandemic • HIV/AIDS in Malawi • polio vaccine • Spanish flu • West African Ebola virus epidemic

Virus–Host interactions: antibody • host • immune system • parasitism • RNA interference

Methodology: metagenomics

Social & Media: And the Band Played On • Contagion • "Flu Season" • Frank's Cock • Race Against Time: Searching for Hope in AIDS-Ravaged Africa • social history of viruses • "Steve Burdick" • "The Time Is Now" • "What Lies Below"

People: Brownie Mary • Macfarlane Burnet • Bobbi Campbell • Aniru Conteh • people with hepatitis C • HIV-positive people • Bette Korber • Henrietta Lacks • Linda Laubenstein • Barbara McClintock • poliomyelitis survivors • Joseph Sonnabend • Eli Todd • Ryan White

Selected virus

Electron micrograph of two Epstein–Barr virus particles

Epstein–Barr virus (EBV) (also human herpesvirus 4) is a DNA virus in the Herpesviridae family which infects humans. The virion is around 122–180 nm in diameter. As in all herpesviruses, the nucleocapsid is surrounded by a protein tegument, as well as an envelope. The double-stranded DNA genome is about 172 kb, with 85 genes, making it one of the more complex viruses.

Transmission is via saliva and genital secretions. The virus infects epithelial cells in the pharynx and B cells of the immune system, producing virions by budding. EBV also becomes latent in B cells, possibly in the bone marrow, allowing the infection to persist lifelong. In the latent state, the linear genome is made circular and replicates in the nucleus separately from the host DNA as an episome. Reactivation is poorly understood but is thought to be triggered by the B cell responding to other infections. EBV infection occurs in around 95% of people. Infectious mononucleosis or glandular fever can occur when first infection is delayed until adolescence or adulthood. EBV is associated with some types of cancer, including Burkitt's lymphoma and nasopharyngeal carcinoma. In people with HIV, it can cause hairy leukoplakia and central nervous system lymphomas.

Did you know?

P19 protein dimer
P19 protein dimer

Selected biography

Randy Shilts (8 August 1951 – 17 February 1994) was an American journalist, author and AIDS activist. The first openly gay reporter for a mainstream US newspaper, Shilts covered the unfolding story of AIDS and its medical, social, and political ramifications from the first reports of the disease in 1981. New York University's journalism department later ranked his 1981–85 AIDS reporting in the top fifty works of American journalism of the 20th century. His extensively researched account of the early days of the epidemic in the US, And the Band Played On Politics, People, and the AIDS Epidemic, first published in 1987, brought him national fame. The book won the Stonewall Book Award and was made into an award-winning film. Shilts saw himself as a literary journalist in the tradition of Truman Capote and Norman Mailer. His writing has a powerful narrative drive and interweaves personal stories with political and social reporting.

He received the 1988 Outstanding Author award from the American Society of Journalists and Authors, the 1990 Mather Lectureship at Harvard University, and the 1993 Lifetime Achievement Award from the National Lesbian and Gay Journalists' Association. He died of AIDS in 1994.

In this month

Smallpox vaccination kit, including the bifurcated needle used to administer the vaccine

1 January 1934: Discovery of mumps virus by Claud Johnson and Ernest Goodpasture

1 January 1942: Publication of George Hirst's paper on the haemagglutination assay

1 January 1967: Start of WHO intensified eradication campaign for smallpox (vaccination kit pictured)

3 January 1938: Foundation of March of Dimes, to raise money for polio

6 January 2011: Andrew Wakefield's paper linking the MMR vaccine with autism described as "fraudulent" by the BMJ

25 January 1988: Foundation of the International AIDS Society

29 January 1981: Influenza haemagglutinin structure published by Ian Wilson, John Skehel and Don Wiley, the first viral membrane protein whose structure was solved

Selected intervention

Ball-and-stick model of nevirapine

Nevirapine (also Viramune) is an antiretroviral drug used in the treatment of HIV/AIDS caused by HIV-1. It was the first non-nucleoside reverse transcriptase inhibitor to be licensed, which occurred in 1996. Like nucleoside inhibitors, nevirapine inhibits HIV's reverse transcriptase enzyme, which copies the viral RNA into DNA and is essential for its replication. Unlike nucleoside inhibitors, it binds not in the enzyme's active site but in a nearby hydrophobic pocket, causing a conformational change in the enzyme that prevents it from functioning. Mutations in the pocket generate resistance to nevirapine, which develops rapidly unless viral replication is completely suppressed. The drug is therefore only used together with other anti-HIV drugs in combination therapy. The HIV-2 reverse transcriptase has a different pocket structure, rendering it inherently resistant to nevirapine and other first-generation NNRTIs. A single dose of nevirapine is a cost-effective way to reduce mother-to-child transmission of HIV, and has been recommended by the World Health Organization for use in resource-poor settings. Other protocols are recommended in the United States. Rash is the most common adverse event associated with the drug.

Subcategories

Topics

Things to do

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

MedicineMicrobiologyMolecular & Cellular BiologyVeterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: